Nalaganje...
A glypican-3-derived peptide vaccine against hepatocellular carcinoma
The results of a Phase I clinical trial in which a glypican-3 (GPC3)-derived peptide was tested in advanced hepatocellular carcinoma patients point to a strong correlation between immunological and clinical responses. This commentary reviews our fundamental studies and clinical trials on the GPC3-de...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Landes Bioscience
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3518534/ https://ncbi.nlm.nih.gov/pubmed/23243625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.21351 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|